142 related articles for article (PubMed ID: 7779086)
1. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
Zhang ML; Sugawa H; Kosugi S; Mori T
Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of the thyrotropin receptor by mutating CYS-636 in the sixth transmembrane segment.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1996 May; 222(3):713-7. PubMed ID: 8651910
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
4. The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor.
Rossi M; Dimida A; Dell'anno MT; Trincavelli ML; Agretti P; Giorgi F; Corsini GU; Pinchera A; Vitti P; Tonacchera M; Maggio R
J Pharmacol Exp Ther; 2007 Jan; 320(1):465-74. PubMed ID: 17062616
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.
Fournes B; Monier R; Michiels F; Milgrom E; Misrahi M; Feunteun J
Oncogene; 1998 Feb; 16(8):985-90. PubMed ID: 9519872
[TBL] [Abstract][Full Text] [Related]
6. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
8. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
Kosugi S; Shenker A; Mori T
FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
[TBL] [Abstract][Full Text] [Related]
10. Identification of TSH receptor mutations in three families with resistance to TSH.
Tonacchera M; Di Cosmo C; De Marco G; Agretti P; Banco M; Perri A; Gianetti E; Montanelli L; Vitti P; Pinchera A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):712-8. PubMed ID: 17697008
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding.
Hidaka A; Ban T; Panesar NS; Minegishi T; Kohn LD; Tahara K
Thyroid; 1994; 4(4):447-57. PubMed ID: 7711510
[TBL] [Abstract][Full Text] [Related]
12. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
Mueller S; Jaeschke H; Paschke R
Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930
[TBL] [Abstract][Full Text] [Related]
13. Possible difference in glycosylation of the thyrotropin receptor among species.
Kosugi S; Akamizu T; Mori T
Biochem Biophys Res Commun; 1994 May; 200(3):1207-13. PubMed ID: 8185569
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
Hidaka A; Minegishi T; Kohn LD
Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
[TBL] [Abstract][Full Text] [Related]
15. Point mutations of the thyrotropin receptor determining structural requirements for its ability to bind thyrotropin and to stimulate adenylate cyclase activity.
Gustavsson B; Westermark B; Heldin NE
Biochem Biophys Res Commun; 1994 Mar; 199(2):612-8. PubMed ID: 8135801
[TBL] [Abstract][Full Text] [Related]
16. Thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) prevents internalization of TSH receptor.
Picchietti S; Belardinelli M; Taddei AR; Fausto AM; Pellegrino M; Maggio R; Rossi M; Giorgi F
Cell Tissue Res; 2009 Apr; 336(1):31-40. PubMed ID: 19214582
[TBL] [Abstract][Full Text] [Related]
17. Both the 5' and 3' noncoding regions of the thyrotropin receptor messenger ribonucleic acid influence the level of receptor protein expression in transfected mamalian cells.
Kakinuma A; Chazenbalk G; Filetti S; McLachlan SM; Rapoport B
Endocrinology; 1996 Jul; 137(7):2664-9. PubMed ID: 8770884
[TBL] [Abstract][Full Text] [Related]
18. Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells.
Chazenbalk GD; Kakinuma A; Jaume JC; McLachlan SM; Rapoport B
Endocrinology; 1996 Nov; 137(11):4586-91. PubMed ID: 8895321
[TBL] [Abstract][Full Text] [Related]
19. Recombinant thyrotropin stimulates cAMP formation in CHO-K1 cells expressing recombinant chorionic gonadotropin receptor.
Gunji K; Endo T; Ohno M; Minegishi T; Onaya T
Biochem Biophys Res Commun; 1993 Dec; 197(3):1530-5. PubMed ID: 8280172
[TBL] [Abstract][Full Text] [Related]
20. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
